Pharma IQ Glossary: Carcinogenicity
Carcinogenicity, or a carcinogen, is any substance, radionuclide or radiation, that is an agent directly involved in causing cancer. This may be due to the ability to damage the genome or to the disruption of cellular metabolic processes. Several radioactive substances are considered carcinogens, but their carcinogenic activity is attributed to the radiation, for example gamma rays and alpha particles, which they emit. Carcinogenicity of radiation depends of the type of radiation, type of exposure, and penetration.
Success and Accuracy in Genotoxicity and Carcinogenicity Testing: An FDA Perspective
September 21 by Pharma IQDr. Timothy Robison, Pharmacology/Toxicology Reviewer at the US Food and Drug Administration/CDER, joins Helen Winsor from Pharma IQ, to share the latest insights into achieving successful characteris...
FDA Representative Gives Insights into Success and Accuracy in Genotoxicity and Carcinogenicity Testing in Exclusive Podcast Interview
September 09 by Pharma IQ NewsPharma IQ has interviewed Dr. Timothy Robison, Pharmacology and Toxicity Reviewer at the US Food & Drug Administration (FDA) and CDER, in an exclusive podcast ahead of his presentations at the Gen...
How to Identify and Control Genotoxic Impurities
August 08 by Pharma IQDr. Andrew Teasdale, Senior QA Executive at AstraZeneca, joins Helen Winsor from Pharma IQ, to discuss genotoxicity and carcinogenicity testing. He begins by summing up the challenges that exist with...
